Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes

Phytomedicine

Volumn 16, Issue 10, 2009, Pages 942-949

  Gallant, M ^a   Odei Addo, F ^a   Frost, C L ^a   Levendal, R A ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

9 THC; 3T3 L1; Cannabis; Insulin resistance; TNF ; Type 2 diabetes

Indexed keywords

CANNABIS; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LIPID; TETRAHYDROCANNABINOL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL METABOLISM; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPHILICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CANNABIS; GLUCOSE; INSULIN; INSULIN RESISTANCE; MICE; PLANT EXTRACTS; TETRAHYDROCANNABINOL; TRIGLYCERIDES;

BOVINAE; CANNABIS;

EID: 69849093231     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.02.013     Document Type: Article

References (24)

1. Coetzee C., Levendal R.-A., Davids H., van de Venter M., and Frost C.L. Anticoagulant effect of Cannabis extract in an obese rat model. Phytomedicine 14 (2007) 333-337
2. Carvalho E., Jannson P.A., Nagaev I., Wenthzel A., and Smith U. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT 4 expression and impaired insulin stimulated glucose transport. FASEB Journal 10 (2001) 1096
3. Duan C., Yang H., White M.F., and Rui L. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Molecular and Cellular Biology 24 (2004) 7435-7443
4. Hall, W., Dedegenhardt, L., Lynskey, M., 2003. Effects of cannabis use: the health and psychological effects of cannabis use. Monograph Series. No. 25.
5. Heart E., Choi W., and Sung C. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes. American Journal of Physiology 278 (2000) 103-112
6. Hemati N., Ross S.E., Erickson R.L., Groblewski G.E., and MacDougald O.A. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein α (C/EBPα) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. Journal of Biological Chemistry 272 (1997) 25913-25919
7. Kahn B., and Flier J. Obesity and Insulin resistance. Journal of Clinical Investigation 106 (2000) 473-481
8. Klein T.W., Lane B., Newton C.A., and Friedman H. The Cannabinoid system and cytokine network. Experimental Biology and Medicine 225 (2000) 1-8
9. Leahy J.L. Pathogenesis of Type 2 diabetes mellitus. Archives of Medical Research 36 (2005) 197-209
10. Muredach P., Reilly M.P., and Rader D.J. The metabolic syndrome more than the sum of its parts?. Circulation 108 (2003) 1546-1551
11. Nishimura F., and Murayama Y. Periodontal inflammation and insulin resistance - lessons from obesity. Journal of Dental Research 80 (2001) 1690-1694
12. Peraldi P., Hotamisliqil G.S., Buurman W.A., White M.F., and Speegelman B.M. Tumor necrosis factor (TNF)-α inhibits insulin signaling through Stimulation of the p55 TNF receptor and activation of Sphingomyelinase. Journal of Biological Chemistry 271 (1996) 13018-13022
13. Qi H., and Pekala P.H. Tumor necrosis factor-α-induced insulin resistance in adipocytes. Society for Experimental Biology and Medicine 223 (2000) 128-135
14. Ramerez-Zacarias J.L., Castro-Munozledo F., and Kuri-Harcush W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O. Histochemistry 97 (1992) 493-497
15. Robson P. Therapeutic aspects of cannabis and cannabinoids. British Journal of Psychiatry 178 (2001) 107-115
16. Ross S., Gulve E., and Wang M. Chemistry and biochemistry of Type 2 diabetes. Chemical Review 104 (2004) 1255-1282
17. Santuré M., Pitre M., Gaudreault N., Marette A., Nadeau A., and Bachelard H. Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats. American Journal of Physiological Gastrointestinal Liver Physiology 278 (2000) G682-G692
18. Senn J., Klover P., Nowak I., Zimmers T., Koniaris G., Furlentto R., and Mooney R. Suppressor of cytokine signaling -3 (SOCS-3), a potential mediator of Interleukin-6-dependent insulin resistance in hepatocytes. Journal of Biological Chemistry 278 (2003) 13740-13746
19. Straus S.A. Immunoactive cannabinoids: therapeutic prospects for marijuana constituents. Proceedings of National Academic Science 97 (2000) 9363-9364
20. Trillou C.R., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., and Soubrié P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. American Journal of Regulative Integrative Comparative Physiology 284 2 (2002) R345-R353
21. Turner J.C., and Mahlberg P.G. The Cannabinoids: Chemical, Pharmacological and Therapeutic Agents (1984), Academic Press, USA pp. 79-88
22. van Wyk B.-E., and Gericke N. A guide to useful plants of southern Africa (2000), Briza Publications, South Africa p. 158
23. Van Wyk B.-E., van Oudtshoorn B., and Gericke N. Medicinal plants of South Africa (1997), Briza Publications, South Africa p. 66
24. Wild S., Roglic G., Sicree R., King H., and Green A. Diabetes Care 27 (2004) 1047-1053